|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
Q2 FY2021
As of Jun 30, 2021
|
Q1 FY2021
As of Mar 31, 2021
|
Q4 FY2020
As of Dec 31, 2020
|
Q3 FY2020
As of Sep 30, 2020
|
Q2 FY2020
As of Jun 30, 2020
|
Q1 FY2020
As of Mar 31, 2020
|
Q4 FY2019
As of Dec 31, 2019
|
Q3 FY2019
As of Sep 30, 2019
|
Q2 FY2019
As of Jun 30, 2019
|
Q1 FY2019
As of Mar 31, 2019
|
Q4 FY2018
As of Dec 31, 2018
|
Q3 FY2018
As of Sep 30, 2018
|
Q2 FY2018
As of Jun 30, 2018
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||||||||||||
| Current assets: | |||||||||||||||||||
| Cash and cash equivalents, at carrying value | |||||||||||||||||||
| Marketable securities | |||||||||||||||||||
| Prepaid expenses and other current assets | |||||||||||||||||||
| Accounts receivable, net | |||||||||||||||||||
| Inventory, net | |||||||||||||||||||
| Total current assets | |||||||||||||||||||
| Non-current assets: | |||||||||||||||||||
| Intangibles, net | |||||||||||||||||||
| Marketable securities | |||||||||||||||||||
| Fixed assets, net | |||||||||||||||||||
| Operating lease right-of-use assets | |||||||||||||||||||
| Other assets | |||||||||||||||||||
| Total non-current assets | |||||||||||||||||||
| Total assets | |||||||||||||||||||
| LIABILITIES AND STOCKHOLDERS’ EQUITY | |||||||||||||||||||
| Current liabilities: | |||||||||||||||||||
| Accounts payable | |||||||||||||||||||
| Product milestones payable | |||||||||||||||||||
| Accrued expenses and other current liabilities | |||||||||||||||||||
| Deferred revenue | |||||||||||||||||||
| Total current liabilities | |||||||||||||||||||
| Debt, long-term | |||||||||||||||||||
| Deferred revenue, net of current portion | |||||||||||||||||||
| Operating lease liabilities, long-term | |||||||||||||||||||
| Total liabilities | |||||||||||||||||||
| Stockholders’ equity: | |||||||||||||||||||
| Common stock, $0.0001 par value; 150,000,000 shares authorized; 87,667,699 shares issued and outstanding at December 31, 2022; 63,374,738 shares issued and outstanding at December 31, 2021 | |||||||||||||||||||
| Additional paid-in capital | |||||||||||||||||||
| Accumulated other comprehensive loss | |||||||||||||||||||
| Accumulated deficit | |||||||||||||||||||
| Total stockholders’ equity | |||||||||||||||||||
| Total liabilities and stockholders’ equity | |||||||||||||||||||
Loading...
